Nectar Lifesciences has informed that a meeting of the Board of Directors of the company will be held on December 14, 2016 to consider and approve, amongst items, the Unaudited Financial Results of the Company for the Quarter ended on September 30, 2016. Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, they wish to inform that the trading window of the Company shall stand closed from December 07, 2016 to December 16, 2016.
The above information is a part of company’s filings submitted to BSE.